304 related articles for article (PubMed ID: 19786090)
1. Downregulation of stathmin expression is mediated directly by Egr1 and associated with p53 activity in lung cancer cell line A549.
Fang L; Min L; Lin Y; Ping G; Rui W; Ying Z; Xi W; Ting H; Li L; Ke D; Jihong R; Huizhong Z
Cell Signal; 2010 Jan; 22(1):166-73. PubMed ID: 19786090
[TBL] [Abstract][Full Text] [Related]
2. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
Yu J; Baron V; Mercola D; Mustelin T; Adamson ED
Cell Death Differ; 2007 Mar; 14(3):436-46. PubMed ID: 16990849
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Watanabe J; Kawaguchi M; Okayasu I
J Pathol; 2008 Dec; 216(4):521-32. PubMed ID: 18798221
[TBL] [Abstract][Full Text] [Related]
4. p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines.
Mukhopadhyay T; Roth JA
Anticancer Res; 1996; 16(1):105-12. PubMed ID: 8615594
[TBL] [Abstract][Full Text] [Related]
5. Early growth response gene-1 plays a pivotal role in down-regulation of a cohort of genes in uterine leiomyoma.
Ishikawa H; Shozu M; Okada M; Inukai M; Zhang B; Kato K; Kasai T; Inoue M
J Mol Endocrinol; 2007 Nov; 39(5):333-41. PubMed ID: 17975260
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction.
Ahn J; Murphy M; Kratowicz S; Wang A; Levine AJ; George DL
Oncogene; 1999 Oct; 18(43):5954-8. PubMed ID: 10557083
[TBL] [Abstract][Full Text] [Related]
7. c-Abl regulates early growth response protein (EGR1) in response to oxidative stress.
Stuart JR; Kawai H; Tsai KK; Chuang EY; Yuan ZM
Oncogene; 2005 Dec; 24(55):8085-92. PubMed ID: 16091742
[TBL] [Abstract][Full Text] [Related]
8. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer.
Ogishima T; Shiina H; Breault JE; Terashima M; Honda S; Enokida H; Urakami S; Tokizane T; Kawakami T; Ribeiro-Filho LA; Fujime M; Kane CJ; Carroll PR; Igawa M; Dahiya R
Oncogene; 2005 Oct; 24(45):6765-72. PubMed ID: 16007175
[TBL] [Abstract][Full Text] [Related]
9. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.
Marreiros A; Dudgeon K; Dao V; Grimm MO; Czolij R; Crossley M; Jackson P
Oncogene; 2005 Jan; 24(4):637-49. PubMed ID: 15580298
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Egr-1 in HGF-induced elevation of the human 5alpha-R1 gene in human hepatocellular carcinoma cells.
Rui C; Li C; Xu W; Zhan Y; Li Y; Yang X
Biochem J; 2008 Apr; 411(2):379-86. PubMed ID: 18215136
[TBL] [Abstract][Full Text] [Related]
11. Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation.
Hanafusa T; Shinji T; Shiraha H; Nouso K; Iwasaki Y; Yumoto E; Ono T; Koide N
BMC Cancer; 2005 Jan; 5():9. PubMed ID: 15661074
[TBL] [Abstract][Full Text] [Related]
12. Early growth response-1 mediates downregulation of telomerase in cervical cancer.
Akutagawa O; Nishi H; Kyo S; Terauchi F; Yamazawa K; Higuma C; Inoue M; Isaka K
Cancer Sci; 2008 Jul; 99(7):1401-6. PubMed ID: 18460021
[TBL] [Abstract][Full Text] [Related]
13. p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers.
Zhang DW; Jeang KT; Lee CG
Oncogene; 2006 Apr; 25(16):2318-27. PubMed ID: 16501612
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of DNA polymerase kappa in human lung cancer is associated with p53 inactivation: Negative regulation of POLK promoter activity by p53.
Wang Y; Seimiya M; Kawamura K; Yu L; Ogi T; Takenaga K; Shishikura T; Nakagawara A; Sakiyama S; Tagawa M; O-Wang J
Int J Oncol; 2004 Jul; 25(1):161-5. PubMed ID: 15202001
[TBL] [Abstract][Full Text] [Related]
15. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
Li C; Lin M; Liu J
Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
[TBL] [Abstract][Full Text] [Related]
16. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
[TBL] [Abstract][Full Text] [Related]
17. Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas.
Valbuena A; Suárez-Gauthier A; López-Rios F; López-Encuentra A; Blanco S; Fernández PL; Sánchez-Céspedes M; Lazo PA
Lung Cancer; 2007 Dec; 58(3):303-9. PubMed ID: 17689819
[TBL] [Abstract][Full Text] [Related]
18. Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells.
Kang Y; Hong JA; Chen GA; Nguyen DM; Schrump DS
Oncogene; 2007 Jun; 26(30):4394-403. PubMed ID: 17260018
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
20. [Alteration of early growth response 1 expression in gastroenterological cancers and its biological significance].
An J; Guo RF; Zhang L; Geng PL; Lü YY
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1384-9. PubMed ID: 18953875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
